Hypoglycemia in patients with congenital muscle disease

Abstract Background Only a few small studies have previously reported episodes of hypoglycemia in children with neuromuscular diseases; however, there has been no broader investigation into the occurrence of hypoglycemia in children with congenital muscle disease (CMD). Methods Pediatric patients en...

Full description

Bibliographic Details
Main Authors: Leslie H. Hayes, Pomi Yun, Payam Mohassel, Gina Norato, Sandra Donkervoort, Meganne E. Leach, Rachel Alvarez, Anne Rutkowski, Natalie D. Shaw, A. Reghan Foley, Carsten G. Bönnemann
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Pediatrics
Subjects:
Online Access:https://doi.org/10.1186/s12887-020-1909-5
_version_ 1818676685334118400
author Leslie H. Hayes
Pomi Yun
Payam Mohassel
Gina Norato
Sandra Donkervoort
Meganne E. Leach
Rachel Alvarez
Anne Rutkowski
Natalie D. Shaw
A. Reghan Foley
Carsten G. Bönnemann
author_facet Leslie H. Hayes
Pomi Yun
Payam Mohassel
Gina Norato
Sandra Donkervoort
Meganne E. Leach
Rachel Alvarez
Anne Rutkowski
Natalie D. Shaw
A. Reghan Foley
Carsten G. Bönnemann
author_sort Leslie H. Hayes
collection DOAJ
description Abstract Background Only a few small studies have previously reported episodes of hypoglycemia in children with neuromuscular diseases; however, there has been no broader investigation into the occurrence of hypoglycemia in children with congenital muscle disease (CMD). Methods Pediatric patients enrolled in the CMD International Registry (CMDIR) with a history of hypoglycemia were included in this retrospective review. Hypoglycemic episodes and associated clinical and biochemical characteristics were characterized. Results Ten patients with CMD (5 with LAMA2-related muscular dystrophy) reported at least one episode of hypoglycemia beginning at an average age of 3.5 years. Predominant symptoms included altered mental status and nausea/vomiting, and laboratory studies demonstrated metabolic acidosis and ketonuria, consistent with ketotic hypoglycemia. Conclusion Patients with CMD may have an increased risk of hypoglycemia during fasting, illness, or stress due to their relatively low muscle mass and hence, paucity of gluconeogenic substrate. Clinicians should therefore maintain a high index of suspicion for hypoglycemia in this high-risk patient population and caregivers should routinely be trained to recognize and treat hypoglycemia.
first_indexed 2024-12-17T08:47:24Z
format Article
id doaj.art-cc66bc3eb49d4cbe95e9f7527450d77a
institution Directory Open Access Journal
issn 1471-2431
language English
last_indexed 2024-12-17T08:47:24Z
publishDate 2020-02-01
publisher BMC
record_format Article
series BMC Pediatrics
spelling doaj.art-cc66bc3eb49d4cbe95e9f7527450d77a2022-12-21T21:56:10ZengBMCBMC Pediatrics1471-24312020-02-012011710.1186/s12887-020-1909-5Hypoglycemia in patients with congenital muscle diseaseLeslie H. Hayes0Pomi Yun1Payam Mohassel2Gina Norato3Sandra Donkervoort4Meganne E. Leach5Rachel Alvarez6Anne Rutkowski7Natalie D. Shaw8A. Reghan Foley9Carsten G. Bönnemann10Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthNeuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthNeuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthOffice of Biostatistics, National Institute of Neurological Disorders and Stroke, National Institutes of HealthNeuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthNeuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthCongenital Muscle Disease International RegistryCongenital Muscle Disease International RegistryPediatric Neuroendocrinology Group, Clinical Research Branch, National Institute of Environmental Health SciencesNeuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthNeuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of HealthAbstract Background Only a few small studies have previously reported episodes of hypoglycemia in children with neuromuscular diseases; however, there has been no broader investigation into the occurrence of hypoglycemia in children with congenital muscle disease (CMD). Methods Pediatric patients enrolled in the CMD International Registry (CMDIR) with a history of hypoglycemia were included in this retrospective review. Hypoglycemic episodes and associated clinical and biochemical characteristics were characterized. Results Ten patients with CMD (5 with LAMA2-related muscular dystrophy) reported at least one episode of hypoglycemia beginning at an average age of 3.5 years. Predominant symptoms included altered mental status and nausea/vomiting, and laboratory studies demonstrated metabolic acidosis and ketonuria, consistent with ketotic hypoglycemia. Conclusion Patients with CMD may have an increased risk of hypoglycemia during fasting, illness, or stress due to their relatively low muscle mass and hence, paucity of gluconeogenic substrate. Clinicians should therefore maintain a high index of suspicion for hypoglycemia in this high-risk patient population and caregivers should routinely be trained to recognize and treat hypoglycemia.https://doi.org/10.1186/s12887-020-1909-5HypoglycemiaKetotic hypoglycemiaCongenital muscular dystrophiesNeuromuscular
spellingShingle Leslie H. Hayes
Pomi Yun
Payam Mohassel
Gina Norato
Sandra Donkervoort
Meganne E. Leach
Rachel Alvarez
Anne Rutkowski
Natalie D. Shaw
A. Reghan Foley
Carsten G. Bönnemann
Hypoglycemia in patients with congenital muscle disease
BMC Pediatrics
Hypoglycemia
Ketotic hypoglycemia
Congenital muscular dystrophies
Neuromuscular
title Hypoglycemia in patients with congenital muscle disease
title_full Hypoglycemia in patients with congenital muscle disease
title_fullStr Hypoglycemia in patients with congenital muscle disease
title_full_unstemmed Hypoglycemia in patients with congenital muscle disease
title_short Hypoglycemia in patients with congenital muscle disease
title_sort hypoglycemia in patients with congenital muscle disease
topic Hypoglycemia
Ketotic hypoglycemia
Congenital muscular dystrophies
Neuromuscular
url https://doi.org/10.1186/s12887-020-1909-5
work_keys_str_mv AT lesliehhayes hypoglycemiainpatientswithcongenitalmuscledisease
AT pomiyun hypoglycemiainpatientswithcongenitalmuscledisease
AT payammohassel hypoglycemiainpatientswithcongenitalmuscledisease
AT ginanorato hypoglycemiainpatientswithcongenitalmuscledisease
AT sandradonkervoort hypoglycemiainpatientswithcongenitalmuscledisease
AT meganneeleach hypoglycemiainpatientswithcongenitalmuscledisease
AT rachelalvarez hypoglycemiainpatientswithcongenitalmuscledisease
AT annerutkowski hypoglycemiainpatientswithcongenitalmuscledisease
AT nataliedshaw hypoglycemiainpatientswithcongenitalmuscledisease
AT areghanfoley hypoglycemiainpatientswithcongenitalmuscledisease
AT carstengbonnemann hypoglycemiainpatientswithcongenitalmuscledisease